TULIF SURGICAL APPROACH TO ELIMINATING VISIBLE SCARRING
Incubated by IntuitiveX
Many surgeons use an anterior approach to the lumbar spine (Anterior Lumbar Interbody Fusion – ALIF) for its benefits in fusion rate, reduced neurologic risk and to avoid the soft-tissue trauma associated with posterior and lateral spine surgery. However, the anterior approach often leaves a large scar that, for many patients, is objectionable.
NovApproach Spine is developing the TULIF® retro-peritoneal surgical approach which is a patent-protected, less invasive, trans-umbilical pathway to the anterior lumbar spine that effectively eliminates visible scarring.
Open spinal surgery comes with the risk of the large open incision increasing risk of infection, the increased risk of blood loss during surgery, increased healing time with decreased mobility, and increased pain. Other minimally invasive surgical procedures to the spine mitigate these risks, but they do not provide scarless results.
A smaller incision at the navel that disappears within 4 weeks post-op. This provides patients who are body-image conscious with scar-less surgery, reduces surgical trauma, and shortens recovery time. Surgeons receive specialized implant and instruments that enable the procedure as well as a unique way for surgeons to market and grow their practice.
Anterior Spinal Surgery Market (U.S.)
45,000 Anterior spine surgeries performed annually
Target ASP for implant/instrument kit: $5,000
Addressable market: $300M
($115M specific to NovApproach - L3/4 & L4/5)
5% estimated market growth rate
Founder & CEO: Raymond Cloutier
Clinical Advisor: Dr. Michael MacMillan
Technical and Regulatory Advisor: Dawn Lissy
Sales & Marketing Advisor: Michael Wefers
Technical and Business Advisor: Andy Choi
Medical Advisor: Jeff Roh, MD